Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Best Pathway To Interchangeable Insulins Is In The Eye Of The Beholder
May 15 2019
•
By
Sue Sutter
Stakeholders have different views on how to secure interchangeability designations for biosimilar insulins. • Source: Shutterstock
More from Biosimilars
More from Biosimilars & Generics